Variant report
Variant | esv1808238 |
---|---|
Chromosome Location | chr2:52126166-52150034 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | 2:52132828-52140118..2:52144960-52145427 | GM12878 | blood: | |
2 | 2:51675236-51679533..2:52132828-52140118 | GM12878 | blood: | |
3 | 2:51664217-51674289..2:52132828-52140118 | H1-hESC | embryonic stem cell: | embryo |
4 | 2:52132828-52140118..2:52144960-52145427 | GM12878 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17864651 | chr2:52126166-52126167 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs531911257 | chr2:52126186-52126187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs149576698 | chr2:52126191-52126192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373434267 | chr2:52126265-52126266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547618849 | chr2:52126267-52126268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs566152397 | chr2:52126304-52126305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530049560 | chr2:52126368-52126369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548517455 | chr2:52126434-52126435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186183542 | chr2:52126436-52126437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537307136 | chr2:52126457-52126458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545631765 | chr2:52126461-52126462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs28968188 | chr2:52126496-52126497 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs147301863 | chr2:52126513-52126514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552833581 | chr2:52126524-52126525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574436034 | chr2:52126573-52126574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs574942359 | chr2:52126620-52126621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541466802 | chr2:52126688-52126689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556511906 | chr2:52126693-52126694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576345745 | chr2:52126704-52126705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190239448 | chr2:52126709-52126710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs565231931 | chr2:52126719-52126720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs17864652 | chr2:52126727-52126728 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs182824488 | chr2:52126757-52126758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546721083 | chr2:52126772-52126773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs559593754 | chr2:52126777-52126778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12994430 | chr2:52126781-52126782 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs185261826 | chr2:52126803-52126804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs377134899 | chr2:52126836-52126837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570098235 | chr2:52126837-52126838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs530906282 | chr2:52126869-52126870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113424230 | chr2:52126874-52126875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189972331 | chr2:52126888-52126889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570717763 | chr2:52126920-52126921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140913342 | chr2:52126923-52126924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs546729245 | chr2:52126932-52126933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs144972511 | chr2:52126940-52126941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs28965815 | chr2:52126965-52126966 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs556625069 | chr2:52126977-52126978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs13018140 | chr2:52126995-52126996 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs540445962 | chr2:52127027-52127028 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548983970 | chr2:52127067-52127068 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs539034075 | chr2:52127081-52127082 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148576868 | chr2:52127124-52127125 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142072420 | chr2:52127126-52127127 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs370167786 | chr2:52127155-52127156 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs541286676 | chr2:52127158-52127159 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs377379775 | chr2:52127197-52127198 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs28965816 | chr2:52127224-52127225 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs74805608 | chr2:52127239-52127240 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs529075020 | chr2:52127243-52127244 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:52115800-52129400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr2:52127000-52127400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr2:52136000-52136400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr2:52136000-52136600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr2:52144600-52145600 | Enhancers | NHDF-Ad | bronchial |
6 | chr2:52144600-52147800 | Enhancers | Osteobl | bone |
7 | chr2:52144800-52146400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr2:52144800-52146600 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr2:52144800-52147400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr2:52144800-52147600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr2:52144800-52148000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr2:52145000-52145600 | Enhancers | Adipose Nuclei | Adipose |
13 | chr2:52145400-52146600 | Enhancers | HMEC | breast |
14 | chr2:52145600-52146200 | Weak transcription | NHDF-Ad | bronchial |
15 | chr2:52146200-52147200 | Enhancers | NHDF-Ad | bronchial |
16 | chr2:52146400-52146600 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr2:52146400-52148200 | Enhancers | Hela-S3 | cervix |
18 | chr2:52146600-52147400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr2:52147000-52147400 | Enhancers | NHLF | lung |
20 | chr2:52147600-52147800 | Enhancers | Adipose Nuclei | Adipose |
21 | chr2:52147600-52148200 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
22 | chr2:52147800-52151400 | Weak transcription | Osteobl | bone |